Who we are
At ANTOXENLAB, we are at the forefront of developing a new generation of test solutions for detecting chemical contaminants in food and feed. We are an innovative biotech company in the early stages of development, driven by a clear mission: to create high-quality, reliable, and user-friendly immunoassay test kits (including ELISA and Lateral Flow Devices) that enhance food safety around the world.
What sets us apart? While ANTOXENLAB is a young company, our assay development is led by a team with over 25 years of experience in immunological test design and production. This deep expertise lays the foundation for the solid performance and practical usability of our future products.
Our test kits – currently under development – will be designed for the rapid and sensitive detection of:
Antibiotic residues
Mycotoxins (e.g., aflatoxins, ZON, ochratoxin A)
Pesticides
Nitrofuran and other drug metabolites
These contaminants not only pose risks to public health but also create trade barriers. Our goal is to support better quality control, faster certification processes, and full compliance with national and international regulations.
What you can expect from our test kits
Rapid and sensitive detection: Results within 10–30 minutes, with low detection limits (at ppb level)
User-friendly protocols: Minimal training required; ready-to-use kits
Consistent and reproducible results: Produced under validated methods and internal quality control
International compatibility: Compliant with EU and Codex MRLs
Applications:
Food safety laboratories
Animal feed analysis
Export control / customs screening
Quality assurance in the food industry
Working together for safer food chains
At ANTOXENLAB, we believe innovation only matters when it's practical and accessible. That’s why we’re committed to developing test solutions that combine scientific precision with real-world usability — empowering labs, inspectors, and food producers to make confident, informed decisions.
Nermin Sajić
Managing Director | Senior Scientist
After studying Microbiology in the former Yugoslavia, Nermin built a career in the Netherlands as a Senior Scientist at EuroDiagnostica, EuroProxima, and R-Biopharm.
With over 25 years of experience in the development of diverse immunological assays, he has established extensive expertise in the field. In addition, he has contributed to innovative research projects in collaboration with leading academic institutions, including Leiden University Medical Center (LUMC), Wageningen University, and Queen’s University Belfast.